668 related articles for article (PubMed ID: 33941188)
21. "Prescribing for the whole person": A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand.
Norman K; Cassim S; Papa V; Te-Karu L; Clark P; Mullins H; Chepulis L
BMC Health Serv Res; 2023 Oct; 23(1):1058. PubMed ID: 37794403
[TBL] [Abstract][Full Text] [Related]
22. Overview of the uptake and implementation of non-medical prescribing in Wales: a national survey.
Courtenay M; Khanfer R; Harries-Huntly G; Deslandes R; Gillespie D; Hodson K; Morris G; Pritchard A; Williams E
BMJ Open; 2017 Sep; 7(9):e015313. PubMed ID: 28947441
[TBL] [Abstract][Full Text] [Related]
23. Pharmacist independent prescribing in secondary care: opportunities and challenges.
Bourne RS; Baqir W; Onatade R
Int J Clin Pharm; 2016 Feb; 38(1):1-6. PubMed ID: 26613738
[TBL] [Abstract][Full Text] [Related]
24. New Zealand rural primary health care workforce in 2005: more than just a doctor shortage.
Goodyear-Smith F; Janes R
Aust J Rural Health; 2008 Feb; 16(1):40-6. PubMed ID: 18186721
[TBL] [Abstract][Full Text] [Related]
25. Application of concentration ratios to analyze the phenomenon of "next-door" pharmacy in Taiwan.
Ji Chen T; Chou LF; Hwang SJ
Clin Ther; 2006 Aug; 28(8):1225-1230. PubMed ID: 16982300
[TBL] [Abstract][Full Text] [Related]
26. Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.
Poh EW; McArthur A; Stephenson M; Roughead EE
JBI Database System Rev Implement Rep; 2018 Sep; 16(9):1823-1873. PubMed ID: 30204671
[TBL] [Abstract][Full Text] [Related]
27. Pharmacists and nurses as independent prescribers: exploring the patient's perspective.
Hobson RJ; Scott J; Sutton J
Fam Pract; 2010 Feb; 27(1):110-20. PubMed ID: 19858124
[TBL] [Abstract][Full Text] [Related]
28. What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.
Garada M; McLachlan AJ; Schiff GD; Lehnbom EC
BMC Health Serv Res; 2017 Nov; 17(1):734. PubMed ID: 29141618
[TBL] [Abstract][Full Text] [Related]
29. Future perspectives on nonmedical prescribing.
Stewart D; Jebara T; Cunningham S; Awaisu A; Pallivalapila A; MacLure K
Ther Adv Drug Saf; 2017 Jun; 8(6):183-197. PubMed ID: 28607668
[TBL] [Abstract][Full Text] [Related]
30. Non-medical prescribing of chemotherapy: engaging stakeholders to maximise success?
Lennan E
Ecancermedicalscience; 2014; 8():417. PubMed ID: 24761158
[TBL] [Abstract][Full Text] [Related]
31. Pharmacist integration into general practice in New Zealand.
Haua R; Harrison J; Aspden T
J Prim Health Care; 2019 Jul; 11(2):159-169. PubMed ID: 32171359
[TBL] [Abstract][Full Text] [Related]
32. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study.
Jani M; Birlie Yimer B; Sheppard T; Lunt M; Dixon WG
PLoS Med; 2020 Oct; 17(10):e1003270. PubMed ID: 33057368
[TBL] [Abstract][Full Text] [Related]
33. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Auta A; Strickland-Hodge B; Maz J
Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
[TBL] [Abstract][Full Text] [Related]
34. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position.
Bourne RS; Whiting P; Brown LS; Borthwick M
Int J Pharm Pract; 2016 Apr; 24(2):104-13. PubMed ID: 26420309
[TBL] [Abstract][Full Text] [Related]
35. Supplementary nurse prescribing for patients with skin conditions: a national questionnaire survey.
Carey N; Courtenay M; Burke J
J Clin Nurs; 2007 Jul; 16(7):1230-7. PubMed ID: 17584340
[TBL] [Abstract][Full Text] [Related]
36. Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel.
Husnain SZ; Bukhari NI; Hussain K; Babar ZU; Hashmi FK; Saleem Z; Salman M; Curley L
BMC Health Serv Res; 2019 May; 19(1):328. PubMed ID: 31118096
[TBL] [Abstract][Full Text] [Related]
37. The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactions.
Clark DW; Harrison-Woolrych M
Curr Drug Saf; 2006 May; 1(2):169-78. PubMed ID: 18690928
[TBL] [Abstract][Full Text] [Related]
38. Neuropharmacology and mental health nurse prescribers.
Skingsley D; Bradley EJ; Nolan P
J Clin Nurs; 2006 Aug; 15(8):989-97. PubMed ID: 16879543
[TBL] [Abstract][Full Text] [Related]
39. Reduced community antibiotic dispensing in New Zealand during 2015-2018: marked variation in relation to primary health organisation.
Thomas M; Tomlin A; Duffy E; Tilyard M
N Z Med J; 2020 Jul; 133(1518):33-42. PubMed ID: 32683430
[TBL] [Abstract][Full Text] [Related]
40. The impact of a prescription review and prescriber feedback system on prescribing practices in primary care clinics: a cluster randomised trial.
Lim WY; Hss AS; Ng LM; John Jasudass SR; Sararaks S; Vengadasalam P; Hashim L; Praim Singh RK
BMC Fam Pract; 2018 Jul; 19(1):120. PubMed ID: 30025534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
